PROTEOSTASIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger

Wilmington, Delaware--(Newsfile Corp. - August 25, 2020) - Rigrodsky & Long, P.A. announces that it is investigating Proteostasis Therapeutics, Inc. ("Proteostasis") (NASDAQ GS: PTI) regarding possible breaches of fiduciary duties and other violations of law related to Proteostasis' agreement to merge with Yumanity Therapeutics, Inc. ("Yumanity"). Under the terms of the agreement, Proteostasis will issue a number of shares of Proteostasis common stock to Yumanity shareholders.

To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-proteostasis-therapeutics-inc.

If you would like to discuss this investigation and your rights cost and obligation free, please contact Seth D. Rigrodsky or Gina M. Serra toll free at (888) 969-4242 or by e-mail at info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/62500